Symmetry Peak Management’s iShares Biotechnology ETF IBB Stock Holding History

Symmetry Peak Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-60,000	Closed	-$6.77M	–	131
2015 Q4	$6.77M	Buy	+60,000	New	+$6.51M	0.83%	19
2015 Q2	–	Sell	-30,000	Closed	-$3.43M	–	124
2015 Q1	$3.43M	Sell	30,000 -15,000	-33%	-$1.65M	0.46%	40
2014 Q4	$4.55M	Buy	+45,000	New	+$4.37M	0.81%	28

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Symmetry Peak Management's IBB Position: Q3 2019 in Review

Symmetry Peak Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,500 shares — an estimated $273K sold.

Symmetry Peak Management first reported a position in IBB in Q4 2016 and held it in 4 quarters. The position peaked at $2.33M in Q3 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Symmetry Peak Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Symmetry Peak Management sold 2,500 iShares Biotechnology ETF shares in Q3 2019, an estimated $273K.
Symmetry Peak Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 4 quarters.
Symmetry Peak Management's iShares Biotechnology ETF position peaked at $2.33M in Q3 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Symmetry Peak Management's 13F filing for Q3 2019, filed 14 Nov 2019.